Study detail
RecruitingObservational
Sacral Neuromodulation for Male Overactive Bladder
Axonics, Inc.
Summary
To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
Description
To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients who have a prior history of radical prostatectomy or radiation for prostate cancer or who have a history of cytoreductive surgical intervention for benign prostatic hyperplasia (BPH).
Eligibility
- Age range
- 18+ years
- Sex
- Male
- Healthy volunteers
- No
Detailed criteria